Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hamburg, The Atypical Commissioner, Receives Atypically Fond Farewell

This article was originally published in The Tan Sheet

Executive Summary

Margaret Hamburg’s background in public health, as opposed to academic medicine, was off-putting to some in pharma initially, but she leaves the agency in March with high drug approval numbers, initiatives to improve the OTC monograph and switch programs and increased enforcement in the supplement manufacturing arena.

Advertisement

Related Content

FDA Staying The Course Under Ostroff; Hamburg’s Concerns Remain Focus
FDA Staying The Course Under Ostroff; Hamburg’s Concerns Remain Focus
Examine Tighter Supplement Industry Regulation, Hamburg Tells Congress
FDA Lands Duke’s Califf As Top Deputy, Potential Next Commissioner
‘Breakthrough’ Drugs Get ‘Road-MaPP’ – Complete With Communication Timetable
FDA’s Acting Chief Scientist Offers Vaccine Continuity As Goodman Departs
FDA Wants Compounding Authority Clarified, Congress Not So Sure It’s Necessary
FDA Globalization Efforts Gain Traction Even As Budget Request Emphasizes Old Inspection Model
FDA Has Regulatory Science Plan; Now It Needs Funding
Public Health Trumps User Fee Goals, FDA Leaders Say – But That May Be Good News For Sponsors

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS107486

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel